Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (491-500 of 524) with videos related to

Pageof 53
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2026
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational ImpactMichele Carbone, Christopher Amos, Richard L Attanoos, et al.
Nature Communications|January 19, 2019
ONECUT2 is a driver of neuroendocrine prostate cancerHaiyang Guo, Xinpei Ci, Musaddeque Ahmed, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung CancerSemanti Mukherjee, Chaitanya Bandlamudi, Matthew D Hellmann, et al.
Nature Genetics|September 4, 2012
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerCharles M Rudin, Steffen Durinck, Eric W Stawiski, et al.
Immunity|December 27, 2022
The ectonucleotidase CD39 identifies tumor-reactive CD8<sup>+</sup> T cells predictive of immune checkpoint blockade efficacy in human lung cancerAndrew Chow, Fathema Z Uddin, Michael Liu, et al.
Cancer Discovery|March 25, 2017
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging TherapiesEmmet J Jordan, Hyunjae R Kim, Maria E Arcila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLCMatthew D Hellmann, Barzin Y Nabet, Hira Rizvi, et al.
Journal of the National Cancer Institute|November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung CancersJoshua K Sabari, Michael Offin, Dennis Stephens, et al.
Cancer Discovery|April 20, 2026
LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung CancerRay Pillai, Ali Rashidfarrokhi, Yuan Hao, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Hierarchical classification of immune cell transcriptomes at population-scaleChristopher Beltz, Zekai Qiu, Leon Sadowski, et al.
Pageof 53

Showing results (491-500 of 524) with videos related to

Sort By:
Pageof 53
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2026
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational ImpactMichele Carbone, Christopher Amos, Richard L Attanoos, et al.
Nature Communications|January 19, 2019
ONECUT2 is a driver of neuroendocrine prostate cancerHaiyang Guo, Xinpei Ci, Musaddeque Ahmed, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung CancerSemanti Mukherjee, Chaitanya Bandlamudi, Matthew D Hellmann, et al.
Nature Genetics|September 4, 2012
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerCharles M Rudin, Steffen Durinck, Eric W Stawiski, et al.
Immunity|December 27, 2022
The ectonucleotidase CD39 identifies tumor-reactive CD8<sup>+</sup> T cells predictive of immune checkpoint blockade efficacy in human lung cancerAndrew Chow, Fathema Z Uddin, Michael Liu, et al.
Cancer Discovery|March 25, 2017
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging TherapiesEmmet J Jordan, Hyunjae R Kim, Maria E Arcila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLCMatthew D Hellmann, Barzin Y Nabet, Hira Rizvi, et al.
Journal of the National Cancer Institute|November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung CancersJoshua K Sabari, Michael Offin, Dennis Stephens, et al.
Cancer Discovery|April 20, 2026
LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung CancerRay Pillai, Ali Rashidfarrokhi, Yuan Hao, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Hierarchical classification of immune cell transcriptomes at population-scaleChristopher Beltz, Zekai Qiu, Leon Sadowski, et al.
Pageof 53